Monday , November 20 2017

MoH uses new treatment for lung cancer patients at center – Immunotherapy to boost body’s defenses: Al-Enizi

KUWAIT CITY, May 14, (KUNA): The Health Ministry’s Sheikha Badria center for lung cancer treatment is poised to use “immunotherapy” — which is a new treatment for lung cancer patients — with proven results, announced chief of the center’s lung cancer division Dr Fahad Al-Enizi on Saturday. Immunotherapy is a type of cancer treatment designed to boost the body’s natural defenses to fight cancer.

It uses materials either made by the body or in a laboratory to improve, target, or restore immune systems’ function, said Dr Al-Enizi in a statement to KUNA, on the sideline of a one day medical conference organized by the center on the merits of the new treatment of immunotherapy. He explained that immunotherapy activates a part of the patient’s immune system to fight cancer, helping it to work better to destroy cancer cells.

Growth

The idea is that immunotherapy can stop or slow the growth of cancer cells and keep cancer from spreading to other parts of the body. Treatments can do this by stimulating the immune system to attack cancer cells, said Dr Al- Enizi. The center he heads began using immunotherapy last September and proved to be successful on patients with acceptable levels of side effects, he said, noting that the new treatment was preferable to the standard treatment using chemotherapy.

 

Translate »